Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3 Hydroxy Dl Tyrosine
2. 3,4 Dihydroxyphenylalanine
3. 3,4-dihydroxyphenylalanine
4. 3-hydroxy-dl-tyrosine
5. Beta Hydroxytyrosine
6. Beta-hydroxytyrosine
7. Dihydroxyphenylalanine
8. Dihydroxyphenylalanine Hydrochloride, (2:1)
9. Dopa
1. 63-84-3
2. 3,4-dihydroxy-dl-phenylalanine
3. 2-amino-3-(3,4-dihydroxyphenyl)propanoic Acid
4. 3-(3,4-dihydroxyphenyl)-dl-alanine
5. 3-hydroxytyrosine
6. Dihydroxyphenylalanine
7. Dl-dioxyphenylalanine
8. Dl-dihydroxyphenylalanine
9. Dopa
10. Dl-tyrosine, 3-hydroxy-
11. 3-hydroxy-dl-tyrosine
12. Dl-3,4-dopa
13. Dl-3-hydroxytyrosine
14. (r,s)-dopa
15. (+-)-dopa
16. Dl-beta-(3,4-dihydroxyphenyl)alanine
17. 3',4'-dihydroxyphenylalanine
18. (+-)-3-(3,4-dihydroxyphenyl)alanine
19. 587-45-1
20. D-b-3,4-dihydroxyphenylalanine
21. Chebi:49168
22. Qi9c343r60
23. 2-amino-3-(3,4-dihydroxy-phenyl)-propionic Acid
24. Alanine, 3-(3,4-dihydroxyphenyl)-, Dl-
25. Nsc-16940
26. Tyrosine, 3-hydroxy-
27. D-3-(3,4-dihydroxyphenyl)alanine
28. D-tyrosine, 3-hydroxy-
29. Dl-3,4-dihydroxyphenylalanine
30. Wln: Qvyz1r Cq Dq
31. Einecs 200-566-0
32. Nsc 16940
33. Unii-qi9c343r60
34. Ai3-23874
35. Mfcd00002598
36. Nsc-118368
37. Beta-(3,4-dihydroxyphenyl)-alpha-alanine
38. Alanine, 3-(3,4-dihydroxyphenyl)-, D-
39. D-3-hydroxytyrosine
40. Mfcd00063060
41. Dopa Dl-form
42. Dopa, Dl-
43. Dopa Dl-form [mi]
44. Schembl24360
45. Alpha-amino-hydrocaffeic Acid
46. (.+-.)-dopa
47. 3,4-dihydroxyphenylalanine #
48. Dl-4,5-dihydroxyphenylalanine
49. Bdbm4377
50. Chembl351042
51. Dtxsid8020549
52. Alanine,4-dihydroxyphenyl)-, D-
53. Dl-3',4'-dihydroxyphenylalanine
54. 3(3,4-dihydroxyphenyl)dl-alanine
55. Alanine,4-dihydroxyphenyl)-, Dl-
56. Bcp25747
57. Nsc16940
58. B-(3,4-dihydroxyphenyl)-a-alanine
59. Dl-b-(3,4-dihydroxyphenyl)alanine
60. 3-(3,4-dihydroxyphenyl)-d-alanine
61. Bbl010087
62. Nsc118368
63. Stk801445
64. (.+-.)-3,4-dihydroxyphenylalanine
65. Akos001132704
66. Akos016843592
67. 3,4-dihydroxy-dl-phenylalanine, 97%
68. Gs-6861
69. Pb43103
70. A-amino-3,4-dihydroxy-benzenepropanoate
71. L-dopa; 3,4-dihydroxy-l-phenylalanine
72. Ncgc00015384-02
73. Ncgc00015384-03
74. Ncgc00095195-01
75. Ncgc00095195-02
76. (+/-) 3-(3,4-dihydroxyphenyl)alanine
77. As-81574
78. Bp-12841
79. Dl-.beta.-(3,4-dihydroxyphenyl)alanine
80. Sy010977
81. (.+-.)-3-(3,4-dihydroxyphenyl)alanine
82. Dl-alanine, 3-(3,4-dihydroxy-phenyl)-
83. (+/-)-3,4-dihydroxyphenylalanine
84. 2-amino-3-(3,4-dihydroxyphenyl)propanoate
85. Alpha-amino-3,4-dihydroxy-benzenepropanoate
86. Db-053498
87. Hy-113404
88. A-amino-3,4-dihydroxy-benzenepropanoic Acid
89. Cs-0059346
90. D0599
91. D9503
92. Dl-beta-(3,4-dihydroxyphenyl)-alpha-alanine
93. Ft-0603250
94. Ft-0650636
95. Ft-0667771
96. Ft-0695064
97. Ft-0775213
98. S6083
99. Beta-(3,4-dihydroxyphenyl)-dl-alpha-alanine
100. Alpha-amino-3,4-dihydroxy-benzenepropanoic Acid
101. Alpha-amino-3,4-dihydroxybenzenepropanoic Acid
102. H11952
103. .beta.-(3,4-dihydroxyphenyl)-dl-.alpha.-alanine
104. A834552
105. L001274
106. (2-pyrrolidin-3-yl-ethyl)-carbamic Acid Benzyl Ester
107. Q27121510
108. Z94598614
109. Dd916368-6635-446f-af55-7b416fd65026
110. Im3
Molecular Weight | 197.19 g/mol |
---|---|
Molecular Formula | C9H11NO4 |
XLogP3 | -2.7 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 197.06880783 g/mol |
Monoisotopic Mass | 197.06880783 g/mol |
Topological Polar Surface Area | 104 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 209 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Dopamine Agents
Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)
ABOUT THIS PAGE
A Dl-Dopa manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dl-Dopa, including repackagers and relabelers. The FDA regulates Dl-Dopa manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dl-Dopa API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dl-Dopa supplier is an individual or a company that provides Dl-Dopa active pharmaceutical ingredient (API) or Dl-Dopa finished formulations upon request. The Dl-Dopa suppliers may include Dl-Dopa API manufacturers, exporters, distributors and traders.
Dl-Dopa Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dl-Dopa GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dl-Dopa GMP manufacturer or Dl-Dopa GMP API supplier for your needs.
A Dl-Dopa CoA (Certificate of Analysis) is a formal document that attests to Dl-Dopa's compliance with Dl-Dopa specifications and serves as a tool for batch-level quality control.
Dl-Dopa CoA mostly includes findings from lab analyses of a specific batch. For each Dl-Dopa CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dl-Dopa may be tested according to a variety of international standards, such as European Pharmacopoeia (Dl-Dopa EP), Dl-Dopa JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dl-Dopa USP).
LOOKING FOR A SUPPLIER?